Jeanie Herbert | Senior Director of Investor Relations and Corporate Communications |
Mark Foley | President, Chief Executive Officer |
Dustin Sjuts | Chief Commercial Officer of Aesthetics & Therapeutics |
Toby Schilke | Chief Financial Officer |
Abhay Joshi | Chief Operating Officer, President of R&D and Product Operations |
Annabel Samimy | Stifel |
Ken Cacciatore | Cowen and Company |
Holly Barra | Goldman Sachs |
David Amsellem | Piper Sandler |
Balaji Prasad | Barclays |
Tim Lugo | William Blair |
Seamus Fernandez | Guggenheim |
Dan Clarke | Mizuho Securities |
Serge Belanger | Needham & Company |
Welcome to the Revance Therapeutics fourth quarter and full year 2019 financial results and corporate update conference call. At this time, all participants are in a listen-only mode.
Following managements' prepared remarks, we will hold a Q&A session. [Operator Instructions].
As a reminder, this call is being recorded today, February 24, 2020.